
LifeMD (LFMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.11 | $-0.03 | -266.7 % |
| Q2 | Aug 5, 2026 | $-0.16 | $-0.08 | -100.0 % |
| Q1 | May 6, 2026 | $-0.20 | $-0.13 | -53.8 % |
| Q4 | Mar 9, 2026 | $-0.04 | $0.02 | -300.0 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $44.63M | $48.84M | -8.63 % |
| Q2 | Aug 5, 2026 | $47.30M | $49.14M | -3.75 % |
| Q1 | May 6, 2026 | $50.16M | $48.76M | 2.88 % |
| Q4 | Mar 9, 2026 | $46.87M | $45.06M | 4.00 % |
LifeMD (LFMD) last issued guidance on November 12, 2026 for fiscal year 2026. The company guided revenue in the range of $188M - $191M for the period.
Compared to prior guidance, LifeMD lowered its revenue forecast from a prior range of $205.5M - $212.5M.
LifeMD has issued 29 guidance updates between March 22, 2023 and November 12, 2026. During this period, the company raised its outlook 9 times and lowered it 13 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.08 | $-0.13 | $0.02 |
| Actual | $-0.11 | $-0.16 | $-0.20 | $-0.04 |
| Surprise | -266.7% | -100.0% | -53.8% | -300.0% |
| Revenue | ||||
| Estimate | $48.8M | $49.1M | $48.8M | $45.1M |
| Actual | $44.6M | $47.3M | $50.2M | $46.9M |
| Surprise | -8.63% | -3.75% | +2.88% | +4.00% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.05 | $0.05 | $-0.06 | $-0.05 |
| Revenue | ||||
| Consensus | $46.9M | $53.2M | — | — |